Christian Junghanss (Anna Richter)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 11

Top Venues

International journal of molecular sciences

Cancers

BMC cancer

Cell death discovery

University of Rostock (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Rostock

Germany

MSC

Publications

Clemens Holz, Sandra Lange, Anett Sekora, Gudrun Knuebel, Saskia Krohn, Hugo Murua Escobar, Christian Junghanss, Christian Junghanss
Combined BCL-2 and PI3K/AKT Pathway Inhibition in KMT2A -Rearranged Acute B-Lymphoblastic Leukemia Cells. International journal of molecular sciences 24 (2) (2023)
Clemens Holz, Sandra Lange, Anett Sekora, Gudrun Knuebel, Saskia Krohn, Hugo Murua Escobar, Christian Junghanss, Christian Junghanss
Combined BCL-2 and PI3K/AKT Pathway Inhibition in KMT2A -Rearranged Acute B-Lymphoblastic Leukemia Cells. International journal of molecular sciences 24 (2) (2023)
Clemens Holz, Sandra Lange, Anett Sekora, Gudrun Knuebel, Saskia Krohn, Hugo Murua Escobar, Christian Junghanss, Christian Junghanss
Combined BCL-2 and PI3K/AKT Pathway Inhibition in KMT2A -Rearranged Acute B-Lymphoblastic Leukemia Cells. International journal of molecular sciences 24 (2) (2023)
Clemens Holz, Sandra Lange, Anett Sekora, Gudrun Knuebel, Saskia Krohn, Hugo Murua Escobar, Christian Junghanss, Christian Junghanss
Combined BCL-2 and PI3K/AKT Pathway Inhibition in KMT2A -Rearranged Acute B-Lymphoblastic Leukemia Cells. International journal of molecular sciences 24 (2) (2023)
Pritam Sukul, Christian Junghanss, Christian Junghanss, Jochen K Schubert, Wolfram Miekisch
Origin of breath isoprene in humans is revealed via multi-omic investigations. Communications biology 6 (1) (2023)
Rico Schwarz, Christian Junghanss, Elisabeth Rada Desideria Seiler, Hugo Murua Escobar, Christian Junghanß, Burkhard Hinz
Validation of an LC-MS/MS Method for the Quantification of the CK2 Inhibitor Silmitasertib (CX-4945) in Human Plasma. Molecules (Basel, Switzerland) 27 (8) (2022)
Christian Junghanss, Sandra Lange, Clemens Holz, Luisa Brock, Thomas Freitag, Anett Sekora, Gudrun Knuebel, Saskia Krohn, Rico Schwarz, Burkhard Hinz, Hugo Murua Escobar, Christian Junghanss
Effective tumor cell abrogation via Venetoclax-mediated BCL-2 inhibition in KMT2A-rearranged acute B-lymphoblastic leukemia. Cell death discovery 8 (1) (2022)
Christian Junghanss, Catrin Roolf, Anett Sekora, Gudrun Knuebel, Saskia Krohn, Sandra Lange, Vivien Krebs, Bjoern Schneider, Johannes Lakner, Christoph Wittke, Christoph Kiefel, Irmela Jeremias, Hugo Murua Escobar, Brigitte Vollmar, Christian Junghanss
The Molecular Subtype of Adult Acute Lymphoblastic Leukemia Samples Determines the Engraftment Site and Proliferation Kinetics in Patient-Derived Xenograft Models. Cells 11 (1) (2022)
Christian Junghanss, Elisabeth Fischer, Clemens Holz, Julia Schulze, Sandra Lange, Anett Sekora, Gudrun Knuebel, Larissa Henze, Catrin Roolf, Hugo Murua Escobar, Christian Junghanss
Combined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia. International journal of molecular sciences 22 (5) (2021)
Christian Junghanss, Nina Schoenwaelder, Sina Sender, Christian Junghanss, Claudia Maletzki
Cyclin-Dependent Kinase Inhibitors in Hematological Malignancies-Current Understanding, (Pre-)Clinical Application and Promising Approaches. Cancers 13 (10) (2021)
Anna Richter, Sina Sender, Annemarie Lenz, Rico Schwarz, Burkhard Hinz, Gudrun Knuebel, Anett Sekora, Hugo Murua Escobar, Christian Junghanss, Catrin Roolf
Influence of Casein kinase II inhibitor CX-4945 on BCL6-mediated apoptotic signaling in B-ALL in vitro and in vivo. BMC cancer 20 (1) (2020)

Christian Junghanss.css-eqlu8i{font-size:small;padding-left:4px;} (Anna Richter)

Publication Activity (10 Years)

Top Topics

Top Venues

Christian Junghanss (Anna Richter)